Last February, pharmaceutical giant Merck agreed to pay $100 million to settle accusations that its contraceptive ring NuvaRing can cause fatal health risks. Merck had an option to reject the agreement if less than 95% of the legitimate claimants failed to participate in the deal, USA Today reported on June 5.
However, an announcement made by Merck and the attorneys defending the claimants revealed that the 95% participation rate has been satisfied, which means the agreement will be in force for approximately 3,800 plaintiffs. NuvaRing, a contraceptive device that is 98% effective in preventing pregnancies, has been involved in a series of lawsuits alleging that the device may cause life-threatening health risks, such as heart attack and stroke.
Our team at Ravid & Associates, P.C., believes victims of defective medical products in Detroit, such as NuvaRing, should explore their options in holding its maker accountable for all the damages incurred. To seek help in possibly filing a lawsuit, you may contact us at (248) 948-9696.